Overall Survival Prolonged In Taiho’s Colorectal Cancer Trial
This article was originally published in PharmAsia News
Executive Summary
The nucleoside-based anticancer Lonsurf Combination Tablets (trifluridine/tipiracil hydrochloride) has shown significant prolongation of overall survival in the treatment of colorectal cancer in an international Phase III trial, Taiho Pharmaceuticals recently announced.